文献速递头颈外科

头颈部放疗诱发肉瘤与新生肉瘤的生存与切缘状态

Survival and Margin Status in Head and Neck Radiation-Induced Sarcomas and De Novo Sarcomas.
PubMed 文献 · Otolaryngol Head Neck Surg · 2017-04-11

回顾性病例系列纳入1985年1月1日至2010年1月1日治疗的166例成人头颈部肉瘤患者,其中放疗诱发肉瘤占15.1%、新生肉瘤占84.9%。放疗诱发肉瘤更高级别(P=.006)、更晚期(P=.03),疾病特异性生存(P=.019)和总生存(P=.005)更差;但仅分析高级别软组织肉瘤时两者无统计学显著差异。R0和R1切除的生存优于R2切除及仅放疗/放化疗者。

要点

  • 放疗诱发肉瘤占15.1%,新生肉瘤占84.9%,前者更高级别(P=.006)且更晚期(P=.03)。
  • 放疗诱发肉瘤的疾病特异性生存(P=.019)和总生存(P=.005)较新生肉瘤更差。
  • 仅分析高级别软组织肉瘤时,两者疾病特异性生存(P=.48)和总生存(P=.29)无统计学显著差异。

核心结论

  • 放疗诱发肉瘤较新生肿瘤生存更差,但控制肿瘤级别和切除状态后,观察到的结局无统计学显著差异。

研究设计与样本

  • 回顾性病例系列,附病历回顾,来自三级学术中心。
  • 共纳入166例1985年1月1日至2010年1月1日治疗的成人头颈部肉瘤患者。

主要发现

  • 放疗诱发肉瘤占15.1%,新生肉瘤占84.9%。
  • 放疗诱发肉瘤更高级别(P=.006)且更晚期(P=.03)。
  • 软骨肉瘤在新生肿瘤中更常见(P=.02);平滑肌肉瘤(P=.01)、未另作规定的肉瘤(P=.02)和未分化多形性肉瘤(P<.001)在放疗诱发肉瘤中更常见。
  • 放疗诱发肉瘤较新生肉瘤的疾病特异性生存(P=.019)和总生存(P=.005)更差。
  • 仅分析高级别软组织肉瘤时,疾病特异性生存(P=.48)和总生存(P=.29)无统计学显著差异。

关键数值与推荐

  • R0和R1切除较R2切除(P<.001)及仅放疗/放化疗(P=.005)的疾病特异性生存和总生存统计学更好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To describe histologic subtypes and oncologic outcomes among patients with radiation-induced and de novo sarcomas of the head and neck. Study Design Retrospective case series with chart review. Setting Tertiary academic center. Subject and Methods In total, 166 adult patients with sarcoma of the head and neck treated from January 1, 1985, to January 1, 2010, were included. Tumors were characterized as radiation induced (15.1%) vs de novo sarcomas (84.9%). Clinical and tumor characteristics were compared. The primary outcomes were overall survival (OS) and disease-specific survival (DSS). Results Radiation-induced sarcomas were more likely to be high grade ( P = .006) and advanced stage ( P = .03). Chondrosarcoma was more common in de novo tumors ( P = .02) while leiomyosarcoma ( P = .01), sarcoma not otherwise specified ( P = .02), and undifferentiated pleomorphic sarcoma ( P < .001) were more common in radiation-induced sarcomas. Radiation-induced sarcomas were associated with statistically significantly worse DSS ( P = .019) and OS ( P = .005) compared with de novo sarcomas, but when only high-grade soft tissue sarcomas were analyzed, neither DSS ( P = .48) nor OS ( P = .29) differed. Margin status was a significant predictor of survival as both R0 and R1 resections correlated with statistically better DSS and OS compared with R2 ( P < .001) resections and patients treated with radiation therapy/chemoradiation therapy alone ( P = .005). Conclusion Radiation-induced sarcomas of the head and neck correlate with worse survival compared with de novo tumors; however, when controlling for tumor grade and resection status, there is no statistically significant difference in observed outcomes.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Rosko AJ, Birkeland AC, Chinn SB, et al. Survival and Margin Status in Head and Neck Radiation-Induced Sarcomas and De Novo Sarcomas. Otolaryngol Head Neck Surg. 2017. PMID: 28397585. doi:10.1177/0194599817700389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。